Compare NWPX & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NWPX | PRGO |
|---|---|---|
| Founded | 1966 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | 1996 | 2013 |
| Metric | NWPX | PRGO |
|---|---|---|
| Price | $135.41 | $10.47 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $70.00 | $19.33 |
| AVG Volume (30 Days) | 206.5K | ★ 3.9M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 10.28% |
| EPS Growth | ★ 4.71 | N/A |
| EPS | ★ 1.08 | N/A |
| Revenue | ★ $526,003,000.00 | $800,000.00 |
| Revenue This Year | $6.98 | N/A |
| Revenue Next Year | $3.30 | $1.02 |
| P/E Ratio | $126.09 | ★ N/A |
| Revenue Growth | ★ 6.79 | N/A |
| 52 Week Low | $40.37 | $9.23 |
| 52 Week High | $152.03 | $28.44 |
| Indicator | NWPX | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 50.50 | 48.41 |
| Support Level | $128.24 | $10.37 |
| Resistance Level | $152.03 | $11.81 |
| Average True Range (ATR) | 7.32 | 0.52 |
| MACD | -1.35 | 0.04 |
| Stochastic Oscillator | 27.70 | 33.15 |
NWPX Infrastructure Inc is a manufacturer of water-related infrastructure products, and operates in two segments, Water Transmission Systems (WTS), operating as the Northwest Pipe Company brand, and Precast Infrastructure and Engineered Systems (Precast), which includes the brands NWPX Geneva and NWPX Park. WTS manufactures large-diameter, high-pressure steel pipeline systems for use in water infrastructure applications, which are related to drinking water systems. Precast manufactures stormwater and wastewater technology products, high-quality precast and reinforced concrete products, including reinforced concrete pipe (RCP), manholes, box culverts, vaults, and catch basins, pump lift stations, oil water separators, biofiltration units, and other environmental and engineered solutions.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.